Capital Finance
AI is especially prevalent across biopharma, with 30% of healthcare investment in 2024 going to companies leveraging AI.
The FTC is not targeting private equity or trying to impede investment in healthcare, it's just looking at anticompetitive conduct, says John Saran, a partner at Holland & Knight.
Ten startups participated in a "pitch fest" in which mDETECT Inc. took first place for its development of a highly specialized blood test using DNA sequencing to detect cancer progression, says Josh Di Frances, VP and head of incubation at LG NOVA.
It's the largest project of its kind in state history, the hospital says, and will provide patients with enhanced access to care.
The funds will go to the Marcus Neuroscience Institute to strengthen its integrated neurological and neurosurgical care.
The strategic $745M transaction opens new opportunities for Astrana in Orange County, California, where it has limited operations, says CEO.
The majority of proceeds from the sale of its Medicare businesses will be used for share repurchase, Cigna says.
The deal will allow Summa Health to eliminate $850M in existing debt.
Asabys Partners is looking to invest a funding round of $200 million that includes U.S. investors into early stage companies offering novel solutions, says Maite Malet, director of investments and corporate development.
Healthcare does not need a profit-driven approach to patient outcomes, but it does need private equity, says Vin Phan of Ankura.